{
  "pmcid": "9857805",
  "sha256": "4ad6579d4e386facea0246b7b9c89665bb9189c54fba73f24f8e411254029988",
  "timestamp_utc": "2025-11-09T23:02:34.388168+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.709495798319331,
    "reading_ease": 14.538445378151266,
    "word_count": 238
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Cost-Effectiveness of Fibrinogen Concentrate vs Cryoprecipitate in Cardiac Surgery: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Patients were randomised (1:1)"
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants included 495 adult patients with acquired hypofibrinogenemia post-cardiac surgery."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients were randomised (1:1) to receive either FC (4 g per dose) or cryoprecipitate (10 units per dose)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the cost-effectiveness of fibrinogen concentrate (FC) compared to cryoprecipitate in managing active bleeding in adult cardiac surgery patients."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the number of allogeneic blood products (ABPs) administered within 7 days."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not specified."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Participants included 495 adult patients"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "A total of 495 patients were analysed"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Median 7-day ABP costs were CAD $2280 for FC and CAD $2770 for cryoprecipitate."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were similar across groups."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT03037424"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 18,
    "max_score": 25
  }
}